Inventor · disambiguated record
James G. Moe
Also filed as: MOE JAMES · MOE JAMES G
16 granted patents·12 pending applications·521 citations·filing 1997–2025
94Inventor score
Top patents by PatentIndex Score
28 records- 0196US6300068B1Nucleic acid assaysBIO MERIEUX VITEK INC·Filed 1999·Granted Oct 9, 2001·122 cites·8 claims
- 0293US6586234B1Device for automated detection of nucleic acidsBIO MERIEUX VITEK INC·Filed 1999·Granted Jul 1, 2003·96 cites·11 claims
- 0389US6528632B1Nucleic acid assaysBIOMERIEUX VITEK·Filed 2000·Granted Mar 4, 2003·25 cites·2 claims
- 0488US5786182ADual chamber disposable reaction vessel for amplification reactions, reaction processing station therefor, and methods of useBIO MERIEUX VITEK INC·Filed 1997·Granted Jul 28, 1998·223 cites·25 claims
- 0585US7309588B2Nucleic acid assaysBIO MERIEUX INC·Filed 2001·Granted Dec 18, 2007·11 cites·27 claims
- 0681US11306075B2Benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of useOLIGOMERIX INC·Filed 2017·Granted Apr 19, 2022·2 cites·9 claims
- 0777US10597649B2Tau protease compositions and methods of useOLIGOMERIX INC·Filed 2016·Granted Mar 24, 2020·1 cites·16 claims
- 0877US7262008B2Nucleic acid assaysBIO MERIEUX INC·Filed 2002·Granted Aug 28, 2007·16 cites·10 claims
- 0976US11472776B2Quinazolinones that inhibit the formation of tau oligomers and their method of useOLIGOMERIX INC·Filed 2017·Granted Oct 18, 2022·1 cites·8 claims
- 1076US2025304565A1Novel benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of useOLIGOMERIX INC·Filed 2025·Application pending·0 cites
- 1175US11104710B2Methods and compositions comprising tau oligomersOLIGOMERIX INC·Filed 2016·Granted Aug 31, 2021·1 cites·9 claims
- 1272US9506051B2Tau protease compositions and methods of useMOE JAMES G·Filed 2012·Granted Nov 29, 2016·2 cites·23 claims
- 1371US12331043B2Benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of useOLIGOMERIX INC·Filed 2022·Granted Jun 17, 2025·0 cites·5 claims
- 1470US12060591B2Tau protease compositions and methods of useOLIGOMERIX INC·Filed 2020·Granted Aug 13, 2024·0 cites·5 claims
- 1570US9464122B2Methods and compositions comprising tau oligomersMOE JAMES G·Filed 2009·Granted Oct 11, 2016·3 cites·26 claims
- 1670US2008240985A1Nucleic Acid AssaysBIO MERIEUX INC·Filed 2007·Application pending·0 cites
- 1768US2020087387A1Antibody based reagents that specifically recognize toxic oligomeric forms of tauOLIGOMERIX INC·Filed 2019·Application pending·0 cites
- 1867US2021395319A1Methods and compositions comprising tau oligomersOLIGOMERIX INC·Filed 2021·Application pending·0 cites
- 1964US10465001B2Antibody based reagents that specifically recognize toxic oligomeric forms of tauOLIGOMERIX INC·Filed 2017·Granted Nov 5, 2019·0 cites·22 claims
- 2064US6558901B1Nucleic acid assaysBIOMERIEUX VITEK·Filed 1998·Granted May 6, 2003·18 cites·22 claims
- 2159US2024158357A1Novel quinazolinones that inhibit the formation of tau oligomers and their method of useOLIGOMERIX INC·Filed 2022·Application pending·0 cites
- 2258US2011312059A1Tau protease compositions and methodsMOE JAMES G·Filed 2009·Application pending·0 cites
- 2352US2008241840A1Methods of detection using immuno-Q-Amp technologyQ RNA INC·Filed 2007·Application pending·0 cites
- 2448US2008220449A1Biomarkers and assays for Alzheimer's diseaseOLIGOMERIX INC·Filed 2008·Application pending·0 cites
- 2547US2006199194A1Methods of detection using immuno-Q-Amp technologyQ RNA INC·Filed 2005·Application pending·0 cites
- 2645US2007218491A1Oligomerization of amyloid proteinsOLIGOMERIX INC·Filed 2007·Application pending·0 cites
- 2742US2006257904A1Agglomeration protein cascades, compositions and methods regarding the sameQ RNA INC·Filed 2006·Application pending·0 cites
- 2839US2011027817A1Tau protein screening assayARANCIO OTTAVIO·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James G. Moe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →